Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH, UK.
Laboratory of Neurobiology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.
Mol Neurobiol. 2018 Oct;55(10):8103-8123. doi: 10.1007/s12035-018-0975-2. Epub 2018 Mar 5.
Hyperactivated microglia plays a key role in regulating neuroinflammatory responses which cause damage to neurons. In recent years, substantial attention has been paid in identifying new strategies to abrogate neuroinflammation. Tiliroside, a natural dietary glycosidic flavonoid, is known to inhibit neuroinflammation. This study was aimed at investigating the molecular mechanisms involved in the inhibition of neuroinflammation and neurotoxicity by tiliroside. The effects of tiliroside on Nrf2 and SIRT1 activities in BV2 microglia and HT22 hippocampal neurons were investigated using immunoblotting and DNA binding assays. The roles of Nrf2 and SIRT1 in the anti-inflammatory activity of tiliroside were further investigated using RNA interference experiments. HT22 neuronal viability was determined by XTT, calcium influx, DNA fragmentation assays. The effect of tiliroside on MAP2 protein expression in HT22 neurons was investigated using western blotting and immunofluorescence. We also studied the impact of tiliroside on DNA fragmentation and ROS generation in APPSwe-transfected 3D neuronal stem cells. Results show that tiliroside increased protein levels of Nrf2, HO-1 and NQO1, indicating an activation of the Nrf2 protective mechanisms in the microglia. Furthermore, transfection of BV2 cells with Nrf2 siRNA resulted in the loss of anti-inflammatory activity by tiliroside. Tiliroside reduced protein levels of acetylated-NF-κB-p65, and increased SIRT1 in LPS/IFNγ-activated BV2 microglia. RNAi experiments revealed that inhibition of neuroinflammation by tiliroside was not affected by silencing SIRT1 gene. Results of neurotoxicity experiments revealed that neuroinflammation-induced toxicity, DNA fragmentation, ROS generation and calcium accumulation in HT22 neurons were significantly reduced by tiliroside treatment. In addition, the compound also protected differentiated human neural progenitor cells by blocking ROS generation and DNA fragmentation. Overall, this study has established that tiliroside protected BV2 microglia from LPS/IFNγ-induced neuroinflammation and HT22 neuronal toxicity by targeting Nrf2 antioxidant mechanisms. The compound also produced inhibition of NF-κB acetylation through activation of SIRT1, as well as increasing SIRT1 activity in mouse hippocampal neurons. Results from this study have further established the mechanisms involved in the anti-neuroinflammatory and neuroprotective activities of tiliroside.
过度激活的小胶质细胞在调节导致神经元损伤的神经炎症反应中起着关键作用。近年来,人们越来越关注寻找新的策略来阻断神经炎症。桃叶珊瑚苷是一种天然的膳食糖苷类黄酮,已知可抑制神经炎症。本研究旨在探讨桃叶珊瑚苷抑制神经炎症和神经毒性的分子机制。通过免疫印迹和 DNA 结合测定研究了桃叶珊瑚苷对 BV2 小胶质细胞和 HT22 海马神经元中 Nrf2 和 SIRT1 活性的影响。使用 RNA 干扰实验进一步研究了 Nrf2 和 SIRT1 在桃叶珊瑚苷抗炎活性中的作用。通过 XTT、钙内流、DNA 片段化测定法测定 HT22 神经元活力。通过 Western 印迹和免疫荧光法研究了桃叶珊瑚苷对 HT22 神经元 MAP2 蛋白表达的影响。我们还研究了桃叶珊瑚苷对 APPswe 转染的 3D 神经元干细胞中 DNA 片段化和 ROS 生成的影响。结果表明,桃叶珊瑚苷增加了 Nrf2、HO-1 和 NQO1 的蛋白水平,表明 Nrf2 保护机制在小胶质细胞中被激活。此外,用 Nrf2 siRNA 转染 BV2 细胞导致桃叶珊瑚苷抗炎活性丧失。桃叶珊瑚苷降低了 LPS/IFNγ 激活的 BV2 小胶质细胞中乙酰化-NF-κB-p65 的蛋白水平,并增加了 SIRT1。RNAi 实验表明,抑制 SIRT1 基因并不影响桃叶珊瑚苷抑制神经炎症。神经毒性实验结果表明,桃叶珊瑚苷处理显著降低了 LPS/IFNγ 诱导的 HT22 神经元毒性、DNA 片段化、ROS 生成和钙积累。此外,该化合物还通过阻断 ROS 生成和 DNA 片段化来保护分化的人神经祖细胞。总的来说,这项研究表明,桃叶珊瑚苷通过靶向 Nrf2 抗氧化机制来保护 BV2 小胶质细胞免受 LPS/IFNγ 诱导的神经炎症和 HT22 神经元毒性。该化合物还通过激活 SIRT1 抑制 NF-κB 乙酰化,并增加小鼠海马神经元中的 SIRT1 活性。本研究进一步确定了桃叶珊瑚苷抗神经炎症和神经保护活性的相关机制。